Effects of an Extended Version of the Lee Silverman Voice Treatment on Voice and Speech in Parkinson’s Disease
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Purpose: The present study examined vocal SPL, voice handicap, and speech characteristics in Parkinson’s disease (PD) following an extended version of the Lee Silverman Voice Treatment (LSVT), to help determine whether current treatment dosages can be altered without compromising clinical outcomes. Method: Twelve participants with idiopathic PD received the extended treatment version (LSVT-X), similar to LSVT except that it was administered twice a week in 1-hr sessions over 8 weeks and required substantially more home practice. Recordings were made in a sound-treated booth immediately before and after treatment, and again 6 months later. Vocal SPL was measured for 4 different tasks and compared with data from a previous study, in which participants with PD received traditional LSVT 4 times a week for 4 weeks. Listener ratings were conducted with audio samples from both studies, using sentence pairs from a standard passage. LSVT-X participants completed the Voice Handicap Index (VHI) before each set of recordings. Results: Participants receiving LSVT-X significantly increased vocal SPL by 8 dB after treatment and maintained increased vocal SPL by 7.2 dB at 6 months. VHI scores improved for 25% of the LSVT-X participants following treatment, and listener ratings indicated audible improvement in speech. Conclusions: LSVT-X successfully increased vocal SPL (which was consistent with improvements following traditional LSVT), decreased perceived voice handicap, and improved functional speech in individuals with PD. Further large-scale research is required to truly establish LSVT-X efficacy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Experimental Design: Procedures for the Behavioral Sciences
Kirk, R. (2013) · doi:10.4135/9781483384733 · Cited by 8,539
The Voice Handicap Index (VHI): Development and Validation
Jacobson, B. H., Johnson, A., Grywalski, C., Silbergleit, A., Jacobson, G., Benninger, M. S., & Newman, C. W. (1997) · American Journal of Speech-Language Pathology · doi:10.1044/1058-0360.0603.66 · Cited by 2,574
Intensive voice treatment (LSVT(R)) for patients with Parkinson's disease: a 2 year follow up
Ramig, L. O. (2001) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.71.4.493 · Cited by 481
Self-citationRobertson, S. J., & Thomson, F. (1984) · International Journal of Language & Communication Disorders · doi:10.3109/13682828409029837 · Cited by 113
Cited by
The scientific and clinical basis for the treatment of Parkinson disease (2009)
Olanow, C. W., Stern, M. B., & Sethi, K. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a1d44c · Cited by 908
Fox, C., Ebersbach, G., Ramig, L., & Sapir, S. (2012) · Parkinson's Disease · doi:10.1155/2012/391946 · Cited by 178
Self-citationTickle‐Degnen, L., Ellis, T., Saint‐Hilaire, M. H., Thomas, C. A., & Wagenaar, R. C. (2010) · Movement Disorders · doi:10.1002/mds.22940 · Cited by 167
Be Clear : A New Intensive Speech Treatment for Adults With Nonprogressive Dysarthria
Park, S., Theodoros, D., Finch, E., & Cardell, E. (2016) · American Journal of Speech-Language Pathology · doi:10.1044/2015_ajslp-14-0113 · Cited by 82
Hecker, P., Steckhan, N., Eyben, F., Schuller, B. W., & Arnrich, B. (2022) · Frontiers in Digital Health · doi:10.3389/fdgth.2022.842301 · Cited by 78
Metadata
- Authors
- Spielman, J., Ramig, L. O., Mahler, L., Halpern, A., & Gavin, W. J.
- Venue
- American Journal of Speech-Language Pathology
- Published
- 2007-05
- Volume
- 16
- Issue
- 2
- Pages
- 95-107
- ISSN
- 1058-0360 (ISSN-L)
- 1558-9110
- DOI
- 10.1044/1058-0360(2007/014
- OpenAlex
- W1998034600
- Cited by
- 124
- References
- 4
- FWCI
- 3.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of an Extended Version of the Lee Silverman Voice Treatment on Voice and Speech in Parkinson’s Disease. https://app.cochat.ai/papers/10.1044/1058-0360(2007/014
- The paper
- Spielman, J., Ramig, L. O., Mahler, L., Halpern, A., & Gavin, W. J. (2007). Effects of an Extended Version of the Lee Silverman Voice Treatment on Voice and Speech in Parkinson’s Disease. American Journal of Speech-Language Pathology. https://doi.org/10.1044/1058-0360(2007/014
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.